Citadel Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.78M | Sell |
72,200
-126,000
| -64% | -$10.4M | ﹤0.01% | 4105 |
|
|
2025
Q4 | $16.9M | Sell |
198,200
-124,700
| -39% | -$10.2M | ﹤0.01% | 2565 |
|
|
2025
Q3 | $25.1M | Buy |
322,900
+22,900
| +8% | +$1.79M | ﹤0.01% | 2054 |
|
|
2025
Q2 | $23.5M | Sell |
300,000
-90,200
| -23% | -$6.73M | ﹤0.01% | 1962 |
|
|
2025
Q1 | $28.3M | Sell |
390,200
-682,700
| -64% | -$48.9M | 0.01% | 1658 |
|
|
2024
Q4 | $79.4M | Buy |
1,072,900
+391,000
| +57% | +$27.4M | 0.01% | 885 |
|
|
2024
Q3 | $45M | Buy |
681,900
+206,000
| +43% | +$15M | 0.01% | 1312 |
|
|
2024
Q2 | $44M | Sell |
475,900
-116,200
| -20% | -$10.3M | 0.01% | 1253 |
|
|
2024
Q1 | $56.6M | Sell |
592,100
-173,700
| -23% | -$14.6M | 0.01% | 1111 |
|
|
2023
Q4 | $58.4M | Buy |
765,800
+303,700
| +66% | +$21.1M | 0.01% | 1069 |
|
|
2023
Q3 | $32M | Buy |
462,100
+35,600
| +8% | +$2.86M | 0.01% | 1445 |
|
|
2023
Q2 | $40.2M | Sell |
426,500
-212,900
| -33% | -$18.5M | 0.01% | 1223 |
|
|
2023
Q1 | $52.9M | Sell |
639,400
-42,800
| -6% | -$3.36M | 0.01% | 1023 |
|
|
2022
Q4 | $50.9M | Buy |
682,200
+119,600
| +21% | +$9.22M | 0.01% | 1109 |
|
|
2022
Q3 | $46.5M | Buy |
562,600
+83,200
| +17% | +$8.01M | 0.01% | 1125 |
|
|
2022
Q2 | $45.6M | Buy |
479,400
+139,200
| +41% | +$14.4M | 0.01% | 1093 |
|
|
2022
Q1 | $40M | Sell |
340,200
-100,200
| -23% | -$11.2M | 0.01% | 1286 |
|
|
2021
Q4 | $57.1M | Buy |
440,400
+105,100
| +31% | +$12.3M | 0.01% | 1067 |
|
|
2021
Q3 | $38M | Sell |
335,300
-48,800
| -13% | -$5.57M | 0.01% | 1336 |
|
|
2021
Q2 | $39.8M | Buy |
384,100
+145,400
| +61% | +$13.7M | 0.01% | 1318 |
|
|
2021
Q1 | $20M | Sell |
238,700
-79,800
| -25% | -$6.75M | ﹤0.01% | 1962 |
|
|
2020
Q4 | $29.1M | Sell |
318,500
-92,700
| -23% | -$7.69M | 0.01% | 1427 |
|
|
2020
Q3 | $32.8M | Buy |
411,200
+21,800
| +6% | +$1.7M | 0.01% | 1149 |
|
|
2020
Q2 | $26.9M | Buy |
389,400
+48,000
| +14% | +$3.41M | 0.01% | 1244 |
|
|
2020
Q1 | $21.5M | Sell |
341,400
-84,900
| -20% | -$6.12M | 0.01% | 1185 |
|
|
2019
Q4 | $33.2M | Buy |
426,300
+101,100
| +31% | +$7.89M | 0.01% | 1049 |
|
|
2019
Q3 | $23.8M | Sell |
325,200
-40,800
| -11% | -$2.87M | 0.01% | 1314 |
|
|
2019
Q2 | $22.5M | Sell |
366,000
-135,000
| -27% | -$8.16M | 0.01% | 1323 |
|
|
2019
Q1 | $32M | Buy |
501,000
+58,500
| +13% | +$3.34M | 0.02% | 973 |
|
|
2018
Q4 | $22.6M | Sell |
442,500
-44,700
| -9% | -$2.26M | 0.01% | 1134 |
|
|
2018
Q3 | $28.3M | Sell |
487,200
-74,100
| -13% | -$3.62M | 0.01% | 1123 |
|
|
2018
Q2 | $27.2M | Buy |
561,300
+340,800
| +155% | +$15.9M | 0.01% | 1070 |
|
|
2018
Q1 | $10.3M | Sell |
220,500
-36,000
| -14% | -$1.56M | 0.01% | 1704 |
|
|
2017
Q4 | $9.64M | Buy |
256,500
+10,500
| +4% | +$385K | 0.01% | 1771 |
|
|
2017
Q3 | $8.96M | Sell |
246,000
-15,300
| -6% | -$584K | 0.01% | 1701 |
|
|
2017
Q2 | $10.3M | Sell |
261,300
-25,800
| -9% | -$942K | 0.01% | 1437 |
|
|
2017
Q1 | $9M | Sell |
287,100
-139,800
| -33% | -$4.38M | 0.01% | 1518 |
|
|
2016
Q4 | $13.3M | Buy |
426,900
+113,400
| +36% | +$3.67M | 0.01% | 1150 |
|
|
2016
Q3 | $12.6M | Sell |
313,500
-14,400
| -4% | -$542K | 0.01% | 1175 |
|
|
2016
Q2 | $10.9M | Sell |
327,900
-52,200
| -14% | -$1.79M | 0.01% | 1178 |
|
|
2016
Q1 | $11.2M | Sell |
380,100
-9,000
| -2% | -$248K | 0.01% | 1124 |
|
|
2015
Q4 | $10.2M | Sell |
389,100
-17,700
| -4% | -$460K | 0.01% | 1261 |
|
|
2015
Q3 | $9.64M | Buy |
406,800
+4,200
| +1% | +$101K | 0.01% | 1374 |
|
|
2015
Q2 | $9.56M | Buy |
402,600
+232,800
| +137% | +$5.25M | 0.01% | 1505 |
|
|
2015
Q1 | $4.03M | Sell |
169,800
-37,800
| -18% | -$848K | ﹤0.01% | 2260 |
|
|
2014
Q4 | $4.41M | Sell |
207,600
-154,800
| -43% | -$3.11M | ﹤0.01% | 2097 |
|
|
2014
Q3 | $6.17M | Buy |
362,400
+90,000
| +33% | +$1.42M | 0.01% | 1803 |
|
|
2014
Q2 | $3.9M | Sell |
272,400
-113,400
| -29% | -$1.54M | ﹤0.01% | 2062 |
|
|
2014
Q1 | $4.77M | Sell |
385,800
-158,400
| -29% | -$1.83M | 0.01% | 1827 |
|
|
2013
Q4 | $5.96M | Buy |
544,200
+198,600
| +57% | +$2.24M | 0.01% | 1547 |
|
|
2013
Q3 | $4.01M | Sell |
345,600
-109,200
| -24% | -$1.28M | 0.01% | 1756 |
|
|
2013
Q2 | $5.09M | Buy |
+454,800
| New | +$5.38M | 0.01% | 1560 |
|
Other funds holding EW
VCM
VPM
Citadel Advisors's EW Position: Q1 2026 in Review
Citadel Advisors reduced its Edwards Lifesciences (EW) stake by 76% in Q1 2026, selling an estimated $139M and leaving 519,031 shares worth $41.6M. The position accounts for 0.01% of the portfolio, ranked #1533.
Citadel Advisors first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $996M in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Citadel Advisors held 519,031 shares of Edwards Lifesciences worth $41.6M as of Q1 2026.
- Citadel Advisors sold 1,684,896 Edwards Lifesciences shares in Q1 2026, an estimated $139M.
- Edwards Lifesciences made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1533 holding.
- Citadel Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- Citadel Advisors's Edwards Lifesciences position peaked at $996M in Q2 2025.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.